The Global Self-Injections Market is expected to exceed more than US$ 119 Billion by 2024 at a CAGR of 22.5% in the given forecast period.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include Abbvie, Inc., Antares Pharma, Becton Dickinson & Company, 3M Company, Baxter International Inc., Pfizer Inc., Penjet Corporation, PharmaJet, and Terumo Corporation. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
You Can Find Full Report:https://www.marketresearchengine.com/self-Injections-market
The scope of the report includes a detailed study of global and regional markets on Global Self-Injections Market with the reasons given for variations in the growth of the industry in certain regions.
In this crowded world there are different types of drug delivery available, as the demand for self administered therapies increase because of easy adoption and acceptance by the patient. Patients are spending less time with physicians as self-administered therapies grows as they are playing important role in delivering and administering their treatments. The selection of self-injection systems for a drug therapy can be driven by patients preference. Self-injections are an attractive option for administering drug, therapies at home. Insulin-dependent diabetics and individuals suffering from arthritis generally adopt self-inject medication as it is an easy and a reliable method to self-administer drugs. The patient is well-prepared before self-injection is attempted can prevent the development of self-injection anxiety.
The major driving factors of Global Self-Injections Market are as follows:
- Growing incidence of autoimmune and chronic disease
- Expansion of biologic drugs to treat autoimmune disease
The restraining factors of Global Self-Injections Market are as follows:
- Expensive and sterility of injections
This report provides:
1) An overview of the global market for Global Self-Injections Market and related technologies.
2) Analyses of global market trends, with data from 2015, estimates for 2016 and 2017, and projections of compound annual growth rates (CAGRs) through 2024.
3) Identifications of new market opportunities and targeted promotional plans for Global Self-Injections Market.
4) Discussion of research and development, and the demand for new products and new applications.
5) Comprehensive company profiles of major players in the industry.
The Global Self-Injections Market is segmented on the lines of its route of administration, end user, distribution channel, type, therapeutic, dosage form and regional. Based on route of administration segmentation it covers skin, circulatory/musculoskeletal, organs and central nervous system. Based on end user segmentation it covers patient, physicians, home care settings, others. Based on distribution channel segmentation it covers hospital pharmacies, private clinics, chemist, and online pharmacies. Based on type segmentation it covers devices, formulation. Based on therapeutic segmentation it covers autoimmune diseases, hormonal disorders, oncology, orphan diseases, pain management, respiratory therapy, others. Based on dosage form segmentation it covers single dose, multi dose.The Global Self-Injections Market on geographic segmentation covers various regions such as North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Each geographic market is further segmented to provide market revenue for select countries such as the U.S., Canada, U.K. Germany, China, Japan, India, Brazil, and GCC countries.
The Global Self-Injections Market has been segmented as below:
The Global Self-Injections Market is Segmented on the lines of Route of Administration Analysis, End User Analysis, Distribution channel Analysis, Type Analysis, Therapeutic Analysis, Dosage Form Analysis and Regional Analysis.By Route of Administration Analysis this market is segmented on the basis ofSkin, Circulatory/Musculoskeletal, Organs and Central Nervous System. By End User Analysis this market is segmented on the basis ofPatient sector, Physicians sector, Home Care Settings sector and Others sectors. By Distribution channel Analysis this market is segmented on the basis ofHospital Pharmacies, Private Clinics, Chemist and Online Pharmacies.
By Type Analysis this market is segmented on the basis ofDevices and Formulations. Devices its covers Needle-Free Injectors, Auto Injectors, Pen Injectors and Wearable Injectors. By Therapeutic Analysis this market is segmented on the basis ofAutoimmune Diseases, Hormonal Disorders, Oncology, Orphan Diseases, Pain Management, Respiratory Therapy and Others. By Dosage Form Analysis this market is segmented on the basis ofSingle Dose and Multi-Dose. By Regional Analysis this market is segmented on the basis ofNorth America, Europe, Asia-Pacific and Rest of the world.
Request Sample Report from here:https://www.marketresearchengine.com/self-Injections-market
Table of Contents
2 MARKET SEGMENTATION
3 MARKET OVERVIEW
4 EXECUTIVE SUMMARY
5 PREMIUM INSIGHTS
6 GLOBAL SELF-INJECTION MARKET, REGULATORY
7 GLOBAL SELF-INJECTION MARKET, REIMBUSEMENT
8 GLOBAL SELF-INJECTION MARKET, BY TYPE
9 GLOBAL SELF-INJECTION MARKET, BY APPLICATION
10 GLOBAL SELF-INJECTION MARKET, BY USAGE PATTERN
11 GLOBAL SELF-INJECTION MARKET, BY MODE OF ADMINISTRATION
12 GLOBAL SELF-INJECTION MARKET, BY END USER
13 GLOBAL SELF-INJECTION MARKET, BY DISTRIBUTION CHANNEL
14 GLOBAL SELF-INJECTION MARKET, BY GEOGRAPHY
15 GLOBAL SELF INJECTION MARKET, COMPANY LANDSCAPE
16 COMPANY PROFILES
16.1. ELCAM MEDICALCOMPANY OVERVIEW
16.2. BESPAK (SUBSIDIARY OF CONSORT MEDICAL COMPANY)
16.4. SANDOZ INTERNATIONAL GMBH
16.5. SANDOZ INTERNATIONAL GMBH: REVENUE ANALYSIS
16.6. UNILIFE CORPORATION
16.7. WEST PHARMACEUTICAL SERVICES, INC
16.8. PFIZER INC.
16.9. IMPAX LABORATORIES, INC.
16.10. PENJET CORPORATION
16.11. CROSSJECT NEEDLE-FREE INJECTION SYSTEMS
16.12. WILHELM HASELMEIER GMBH & CO. KG
16.13. ANTARES PHARMA
16.14. BECTON, DICKINSON AND COMPANY
16.15. GERRESHEIMER AG
16.16. MYLAN N.V
16.17. NOVO NORDISK
16.18. OWEN MUMFORD LTD
16.20. SHL GROUP
Other Related Market News:
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States